Mirjam M. de Jong

557 total citations
13 papers, 299 citations indexed

About

Mirjam M. de Jong is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Mirjam M. de Jong has authored 13 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 7 papers in Cancer Research. Recurrent topics in Mirjam M. de Jong's work include Genetic factors in colorectal cancer (7 papers), Cancer Genomics and Diagnostics (5 papers) and DNA Repair Mechanisms (4 papers). Mirjam M. de Jong is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Cancer Genomics and Diagnostics (5 papers) and DNA Repair Mechanisms (4 papers). Mirjam M. de Jong collaborates with scholars based in Netherlands, Australia and Norway. Mirjam M. de Jong's co-authors include Rolf H. Sijmons, Elisabeth G.E. de Vries, Gerard J. te Meerman, Jan H. Kleibeuker, Winette T.A. van der Graaf, Ilja M. Nolte, Robert M.W. Hofstra, Arjen R. Mensenkamp, Edward M. Leter and Michael Schaapveld and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and European Journal of Cancer.

In The Last Decade

Mirjam M. de Jong

11 papers receiving 295 citations

Peers

Countries citing papers authored by Mirjam M. de Jong

Since Specialization

Citations

This map shows the geographic impact of Mirjam M. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam M. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam M. de Jong more than expected).

Fields of papers citing papers by Mirjam M. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam M. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam M. de Jong. The network helps show where Mirjam M. de Jong may publish in the future.

Co-authorship network of co-authors of Mirjam M. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam M. de Jong. A scholar is included among the top collaborators of Mirjam M. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam M. de Jong. Mirjam M. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Cancer risks for MSH6 pathogenic variant carriers 2025 ·European Journal of Cancer ·A. Lam, James G. Dowty, (unknown), (unknown), (unknown), Fonnet E. Bleeker, E. Gómez, Liselotte P. van Hest, Gilles Thomas, (unknown), Mirjam M. de Jong, Tom G.W. Letteboer, Floor A.M. Duijkers, Anja Wagner, (unknown), (unknown), Sanne W. ten Broeke, Aung Ko Win, Mark A. Jenkins, Maartje Nielsen	0
2	Delineating genotype and parent‐of‐origin effect on the phenotype in MSH6‐associated Lynch syndrome 2024 ·Genes Chromosomes and Cancer ·A. Lam, Mar Rodríguez‐Girondo, (unknown), Carli M.J. Tops, (unknown), Gilles Thomas, Floor A.M. Duijkers, Anja Wagner, (unknown), Tom G.W. Letteboer, Mirjam M. de Jong, Sanne W. ten Broeke, Fonnet E. Bleeker, E. Gómez, Mev Dominguez–Valentin, Pål Møller, Manon Suerink, Maartje Nielsen	0
3	Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers 2023 ·Modern Pathology ·A. Lam, (unknown), Carli M.J. Tops, (unknown), Liselotte P. van Hest, Gilles Thomas, Floor A.M. Duijkers, Anja Wagner, (unknown), Tom G.W. Letteboer, Mirjam M. de Jong, Sanne W. ten Broeke, Fonnet E. Bleeker, E. Gómez, Niels de Wind, Tom van Wezel, Hans Morreau, Manon Suerink, Maartje Nielsen	9
4	Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome 2022 ·Gastroenterology ·Iris te Paske, Arjen R. Mensenkamp, Kornelia Neveling, Stéphanie Baert‐Desurmont, Kathleen Claes, Kim De Leeneer, (unknown), (unknown), Rachel S. van der Post, (unknown), Tjakko J. van Ham, Anja Wagner, Mirjam M. de Jong, Edward M. Leter, Maartje Nielsen, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Richarda M. de Voer	17
5	Somatic Nonepigenetic Mismatch Repair Gene Aberrations Underly Most Mismatch Repair–Deficient Lynch-Like Tumors 2020 ·Gastroenterology ·(unknown), Arjen R. Mensenkamp, Irıs D. Nagtegaal, Wendy A.G. van Zelst–Stams, Charlotte J. Dommering, Nicoline Hoogerbrugge, Mirjam M. de Jong, Fonnet E. Bleeker, Edward M. Leter, Tom G.W. Letteboer, Maartje Nielsen, Rachel S. van der Post, (unknown), Richarda M. de Voer, Marjolijn J. L. Ligtenberg	8
6	Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study 2017 ·The Journal of Clinical Endocrinology & Metabolism ·Karin van der Tuin, Arjen R. Mensenkamp, Carli M.J. Tops, Eleonora P.M. Corssmit, Winand N.M. Dinjens, (unknown), Jeroen C. Jansen, Mirjam M. de Jong, Henricus P. M. Kunst, Benno Küsters, Edward M. Leter, Hans Morreau, (unknown), Rogier A. Oldenburg, Liesbeth Spruijt, Frederik J. Hes, Henri Timmers	55
7	Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers 2016 ·Familial Cancer ·(unknown), Thamara E. Osinga, Mirjam M. de Jong, Wim J. Sluiter, Robin P. F. Dullaart, Thera P. Links, Michiel N. Kerstens, Anouk N.A. van der Horst‐Schrivers	21
8	Familial Multiple Myeloma: Report on Two Families and Discussion of Screening Options 2007 ·Hereditary Cancer in Clinical Practice ·Erica H. Gerkes, Mirjam M. de Jong, Rolf H. Sijmons, Edo Vellenga	6
9	No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors 2005 ·European Journal of Cancer ·Mirjam M. de Jong, Ilja M. Nolte, Gerard J. te Meerman, Winette T.A. van der Graaf, Elvira Oosterom, Marcel Bruinenberg, Gerrit van der Steege, Jan C. Oosterwijk, Annemarie H. van der Hout, H. Marike Boezen, Michael Schaapveld, Jan H. Kleibeuker, Elisabeth G.E. de Vries	11
10	Colorectal cancer and the CHEK2 1100delC mutation 2005 ·Genes Chromosomes and Cancer ·Mirjam M. de Jong, Ilja M. Nolte, Gerard J. te Meerman, Winette T.A. van der Graaf, Marcel Mulder, Gerrit van der Steege, Marcel Bruinenberg, Michael Schaapveld, Renée C. Niessen, Maran J.W. Berends, Rolf H. Sijmons, Robert M.W. Hofstra, Elisabeth G.E. de Vries, Jan H. Kleibeuker	24
11	The Human Leukocyte Antigen Region and Colorectal Cancer Risk 2005 ·Diseases of the Colon & Rectum ·Mirjam M. de Jong, Marijke Niens, Ilja M. Nolte, Gerard J. te Meerman, Winette T.A. van der Graaf, Marcel Mulder, Gerrit van der Steege, Marcel Bruinenberg, Michael Schaapveld, Rolf H. Sijmons, Robert M.W. Hofstra, Elisabeth G.E. de Vries, Jan H. Kleibeuker	6
12	No association between two MLH3 variants (S845G and P844L)and colorectal cancer risk 2004 ·Cancer Genetics and Cytogenetics ·Mirjam M. de Jong, Robert M.W. Hofstra, Krista Kooi, Jantine L. Westra, Maran J.W. Berends, Ying Wu, Harry Hollema, Tineke van der Sluis, Winette T.A. van der Graaf, Elisabeth G.E. de Vries, Michael Schaapveld, Rolf H. Sijmons, Gerard J. te Meerman, Jan H. Kleibeuker	12
13	Low-penetrance genes and their involvement in colorectal cancer susceptibility. 2002 ·PubMed ·Mirjam M. de Jong, Ilja M. Nolte, Gerard J. te Meerman, Winette T.A. van der Graaf, Elisabeth G.E. de Vries, Rolf H. Sijmons, Robert M.W. Hofstra, Jan H. Kleibeuker	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact